Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers

Status unconfirmed

Conditions studied: Carcinoma, Basal Cell, Carcinoma, Squamous Cell

In brief

The purpose of the study is to evaluate the ability and efficacy of using a polarization-enhanced reflectance and fluorescence imaging device, PERFIS, (see the Device Brochure) for demarcation of nonmelanoma skin cancer margins prior to surgery. PERFIS is a harmless and non-invasive device that has been used to image biological tissue both in vitro and in vivo. In this study it will be used to image nonmelanoma skin cancer lesions prior to surgery. The use of PERFIS will not affect patient care or treatment decisions in any way. No extra tissue will be used for imaging.

Key facts

Study ID

NCT02666833

Run by

Massachusetts General Hospital

People needed

40

Starts

2016-06-01

Expected to finish

2017-08-01

Last updated by the study team

2016-09-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or female subjects, aged 18 and older, of any race or skin type
• At least one biopsy-proven nonmelanoma skin cancer, scheduled to be treated by Mohs micrographic surgery

You may not qualify if…

• Pregnant women
• Patients with tumors within 1 cm of the eye
• Patients with tumors larger than 2 cm in diameter

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.